Zilver Stent Shows High Event-Free Survival at 2 Years in Patients with PAD – TCTMD

Zilver Stent Shows High Event-Free Survival at 2 Years in Patients with PAD
TCTMD
Among patients with 24-month follow-up, the event-free survival rate was 80% and freedom from TLR was 83.3%. There were 4 total deaths, all of them within ...
Drug-Eluting Peripheral Stent Continues to Show Positive Data at Two YearsPR Newswire (press release)

all 11 news articles »

Related Posts

Comments are closed.